完整後設資料紀錄
DC 欄位語言
dc.contributor.authorHuang, Kuo-Chinen_US
dc.contributor.authorChiu, Yi-Hanen_US
dc.contributor.authorLiao, Kuang-Wenen_US
dc.contributor.authorKe, Chun-Yenen_US
dc.contributor.authorLee, Chung-Jenen_US
dc.contributor.authorChao, Yann-Fen C.en_US
dc.contributor.authorLee, Ru-Pingen_US
dc.date.accessioned2017-04-21T06:56:11Z-
dc.date.available2017-04-21T06:56:11Z-
dc.date.issued2016-09-05en_US
dc.identifier.issn0014-2999en_US
dc.identifier.urihttp://dx.doi.org/10.1016/j.ejphar.2016.05.043en_US
dc.identifier.urihttp://hdl.handle.net/11536/134061-
dc.description.abstractThis study evaluated the effects of acetylsalicylic acid (ASA) on exercise-induced inflammatory response, muscle damage, and liver injury in rats. Wistar-Kyoto (WKY) rats were divided into six groups: control (C), exercise (E), C+20 mg ASA, E+20 mg ASA, C+100 mg/kg ASA, and E+100 mg ASA groups. ASA or a vehicle was orally administered through gavage 1 h before a treadmill test. Upon trial completion, blood was drawn at 1, 12, and 24 h for biochemical analysis, and livers were excised at 24 h for a histological assessment. Our results revealed that 100 mg/kg ASA significantly reduced interleukin (IL)-6 and tumor necrosis factor (TNF)-alpha levels in the E groups; however, the IL-10 level was considerably increased. Moreover, aspartate aminotransferase (AST), alanine aminotransferase (ALT) levels and histological hepatic damage increased significantly in the E+100 mg ASA group compared with the corresponding changes in the E group. These results suggest that the prophylactic administration of particularly high dose ASA alleviates exercise-induced inflammatory response but exacerbates liver injury. (C) 2016 Elsevier B.V. All rights reserved.en_US
dc.language.isoen_USen_US
dc.subjectNonsteroidal antiinflammatory drugen_US
dc.subjectAspirinen_US
dc.subjectExhaustion exerciseen_US
dc.subjectLiver injuryen_US
dc.titleProphylactic acetylsalicylic acid attenuates the inflammatory response but fails to protect exercise-induced liver damage in exercised ratsen_US
dc.identifier.doi10.1016/j.ejphar.2016.05.043en_US
dc.identifier.journalEUROPEAN JOURNAL OF PHARMACOLOGYen_US
dc.citation.volume786en_US
dc.citation.spage204en_US
dc.citation.epage211en_US
dc.contributor.department生物科技學系zh_TW
dc.contributor.departmentDepartment of Biological Science and Technologyen_US
dc.identifier.wosnumberWOS:000380753400023en_US
顯示於類別:期刊論文